Interpretation of Expert Consensus on Diagnosis and Treatment of Cutaneous Basal Cell Carcinoma (2021) by A Multidisciplinary Team

VernacularTitle:基于多学科诊疗的《皮肤基底细胞癌诊疗专家共识(2021)》解读
Author: Hongbing WANG ¹ ; Manxiang WANG ; Li WAN ; Weina CAI ; Jinbo CHEN ; Guoliang PI
Author Information

1. Department of Gynecology and Oncology, Hubei Cancer Hospital, Wuhan 430079, China
Publication Type:Research Article
Keywords: Basal cell carcinoma; Skin; Multidisciplinary team; Interpretation of consensus
From: Cancer Research on Prevention and Treatment 2023;50(4):427-432
CountryChina
Language:Chinese
Abstract: Basal cell carcinoma (BCC) is the most common malignant tumor in dermatology with incidence rising rapidly. Expert consensus on diagnosis and treatment of cutaneous basal cell carcinoma (2021) was published in September 2021 by Skin Tumor Research Center, Chinese Society of Dermatology and Subcommittee on Skin Tumor, China Dermatologist Association. This consensus comprehensively describes the epidemiology, pathogenesis, clinical manifestations, auxiliary examination, pathology, pretreatment assessment, treatment, prognosis, and follow-up education. It offers an important guideline for promoting the standardized diagnosis and treatment of skin BCC in China. In this work, multidisciplinary experts interpreted the main contents of the consensus, including clinicopathological findings, pretreatment assessment, and treatment advance.